The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123234154 12323415 4 F 2016 20160816 20160502 20160822 EXP CA-JNJFOC-20160426673 JANSSEN 66.73 YR E M Y 54.80000 KG 20160822 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123234154 12323415 1 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N GAM08012 0 300 MG LYOPHILIZED POWDER
123234154 12323415 2 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) INFUSION DURATION: NO LESS THAN 2 HOURS N GAM08012 0 300 MG LYOPHILIZED POWDER
123234154 12323415 3 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N GAM08012 0 300 MG LYOPHILIZED POWDER
123234154 12323415 4 PS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N GAM08012 103772 300 MG LYOPHILIZED POWDER
123234154 12323415 5 C ENAPRIL ENALAPRIL 1 Unknown 0 UNSPECIFIED
123234154 12323415 6 C MORPHINE MORPHINE 1 Unknown 0 UNSPECIFIED
123234154 12323415 7 C ALLOPURINOL. ALLOPURINOL 1 Unknown 0 UNSPECIFIED
123234154 12323415 8 C METOPROLOL. METOPROLOL 1 Unknown 0 UNSPECIFIED
123234154 12323415 9 C NITROGLYCERIN. NITROGLYCERIN 1 Unknown 0 PATCH
123234154 12323415 10 C PANTOPRAZOLE PANTOPRAZOLE SODIUM 1 Unknown 0 UNSPECIFIED
123234154 12323415 11 C VITAMIN D CHOLECALCIFEROL 1 Unknown 0 UNSPECIFIED
123234154 12323415 12 C CALCIUM CALCIUM 1 Unknown 0 UNSPECIFIED
123234154 12323415 13 C CYANOCOBALAMIN. CYANOCOBALAMIN 1 Unknown 0 INJECTION
123234154 12323415 14 C GABAPENTIN. GABAPENTIN 1 Unknown 0 UNSPECIFIED
123234154 12323415 15 C ASA ASPIRIN 1 Unknown 0 UNSPECIFIED
123234154 12323415 16 C IMOVANE ZOPICLONE 1 Unknown 0 UNSPECIFIED
123234154 12323415 17 C PREDNISONE. PREDNISONE 1 Unknown 0 UNSPECIFIED
123234154 12323415 18 C HYDROXYUREA. HYDROXYUREA 1 Unknown 0 UNSPECIFIED
123234154 12323415 19 C TESTOSTERONE. TESTOSTERONE 1 Unknown 0 UNSPECIFIED
123234154 12323415 20 C FLEXERIL CYCLOBENZAPRINE HYDROCHLORIDE 1 Unknown 0 UNSPECIFIED
123234154 12323415 21 C NICOTINE. NICOTINE 1 Unknown 0 INHALATION
123234154 12323415 22 C TYLENOL ACETAMINOPHEN 1 Unknown 0 UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123234154 12323415 1 Colitis ulcerative
123234154 12323415 2 Colitis ulcerative
123234154 12323415 3 Colitis ulcerative
123234154 12323415 4 Colitis ulcerative

Outcome of event

Event ID CASEID OUTC COD
123234154 12323415 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
123234154 12323415 Abdominal pain
123234154 12323415 Asthenia
123234154 12323415 Feeling hot
123234154 12323415 Frequent bowel movements
123234154 12323415 General physical health deterioration
123234154 12323415 Haematochezia
123234154 12323415 Hyperhidrosis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123234154 12323415 1 20160314 0
123234154 12323415 2 20160426 0
123234154 12323415 3 20160621 0
123234154 12323415 4 20160816 0